Cargando…

Visualization of fibroblast activation using (68)Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation

BACKGROUND: Pulsed-field ablation (PFA) is a novel ablation modality for atrial fibrillation (AF) ablating myocardium by electroporation without tissue-heating. With its different mechanism of tissue ablation, it is assumed that lesion creation is divergent to thermal energy sources. (68)Ga-fibrobla...

Descripción completa

Detalles Bibliográficos
Autores principales: Kupusovic, Jana, Kessler, Lukas, Bruns, Florian, Bohnen, Jan-Eric, Nekolla, Stephan G., Weber, Manuel M., Lauenroth, Anna, Rattka, Manuel, Hermann, Ken, Dobrev, Dobromir, Rassaf, Tienush, Wakili, Reza, Rischpler, Christoph, Siebermair, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558367/
https://www.ncbi.nlm.nih.gov/pubmed/36944827
http://dx.doi.org/10.1007/s12350-023-03220-8
Descripción
Sumario:BACKGROUND: Pulsed-field ablation (PFA) is a novel ablation modality for atrial fibrillation (AF) ablating myocardium by electroporation without tissue-heating. With its different mechanism of tissue ablation, it is assumed that lesion creation is divergent to thermal energy sources. (68)Ga-fibroblast-activation protein inhibitor (FAPI) PET/CT targets FAP-alpha expressed by activated fibroblasts. We aimed to assess (68)Ga-FAPI uptake in pulmonary veins as surrogate for ablation damage after PFA and cryoballoon ablation (CBA). METHODS: 26 patients (15 PFA, 11 CBA) underwent (68)Ga-FAPI-PET/CT after ablation. Standardized uptake values (SUV) and fibroblast-activation volumes of localized tracer uptake were assessed. RESULTS: Patient characteristics were comparable between groups. In PFA, focal FAPI uptake was only observed in 3/15 (20%) patients, whereas in the CBA cohort, 10/11 (90.9%) patients showed atrial visual uptake. We observed lower values of SUV(max) (2.85 ± 0.56 vs 4.71 ± 2.06, P = 0.025) and FAV (1.13 ± 0.84 cm(3) vs 3.91 ± 2.74 cm(3), P = 0.014) along with a trend towards lower SUV(peak) and SUV(mean) in PFA vs CBA patients, respectively. CONCLUSION: Tissue response with respect to fibroblast activation seems to be less pronounced in PFA compared to established thermal ablation systems. This functional assessment might contribute to a better understanding of lesion formation in thermal and PFA ablation potentially contributing to better safety outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12350-023-03220-8.